Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

Tekijä Spaeth, Erika L., Dembinski, Jennifer L., Sasser, A. Kate, Watson, Keri, Klopp, Ann, Hall, Brett, Andreeff, Michael, Marini, Frank
Julkaistu 2009

Correction: Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

Tekijä Spaeth, Erika L., Dembinski, Jennifer L., Sasser, A. Kate, Watson, Keri, Klopp, Ann, Hall, Brett, Andreeff, Michael, Marini, Frank
Julkaistu 2013

The role of Dickkopf-1 in bone development, homeostasis, and disease

Tekijä Pinzone, Joseph J., Hall, Brett M., Thudi, Nanda K., Vonau, Martin, Qiang, Ya-Wei, Rosol, Thomas J., Shaughnessy, John D.
Julkaistu 2009

STAT3 can be activated through paracrine signaling in breast epithelial cells

Tekijä Sasser A Kate, Hutzen Brian, Ball Sarah, Lieblein Jacqueline C, Lin Huey-Jen, Huang Tim HM, Hall Brett M, Lin Jiayuh
Julkaistu 2008-10-01

STAT3 can be activated through paracrine signaling in breast epithelial cells

Tekijä Lieblein, Jacqueline C, Ball, Sarah, Hutzen, Brian, Sasser, A Kate, Lin, Huey-Jen, Huang, Tim HM, Hall, Brett M, Lin, Jiayuh
Julkaistu 2008

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

Tekijä Casneuf, Tineke, Axel, Amy E, King, Peter, Alvarez, John D, Werbeck, Jillian L, Verhulst, Tinne, Verstraeten, Karin, Hall, Brett M, Sasser, A Kate
Julkaisussa Breast Cancer (Dove Med Press) (2016)

Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6

Tekijä Chaturvedi, Shalini, Siegel, Derick, Wagner, Carrie L, Park, Jaehong, van de Velde, Helgi, Vermeulen, Jessica, Fung, Man-Cheong, Reddy, Manjula, Hall, Brett, Sasser, Kate
Julkaisussa Br J Clin Pharmacol (2015)

Melphalan exposure induces an Interleukin-6 deficit in bone marrow stromal cells and osteoblasts

Tekijä Rellick, Stephanie L., Piktel, Debbie, Walton, Cheryl, Hall, Brett, Petros, William, Fortney, James E., Gencheva, Marieta, Denvir, Jim, Hobbs, Gerald, Craig, Michael, Gibson, Laura F.
Julkaistu 2012

Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor)

Tekijä Lagmay, Joanne P., London, Wendy B., Gross, Thomas G., Termuhlen, Amanda, Sullivan, Nicholas, Axel, Amy, Mundy, Bethany, Ranalli, Mark, Canner, Jason, McGrady, Patrick, Hall, Brett
Julkaistu 2009

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels

Tekijä Stone, Katie, Woods, Emily, Szmania, Susann M., Stephens, Owen W., Garg, Tarun K., Barlogie, Bart, Shaughnessy, John D., Hall, Brett, Reddy, Manjula, Hoering, Antje, Hansen, Emily, van Rhee, Frits
Julkaistu 2013

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα(2) through IRF9

Tekijä Erb, Holger H H, Langlechner, Regina V, Moser, Patrizia L, Handle, Florian, Casneuf, Tineke, Verstraeten, Karin, Schlick, Bettina, Schäfer, Georg, Hall, Brett, Sasser, Kate, Culig, Zoran, Santer, Frédéric R
Julkaistu 2013

NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma

Tekijä Wang, Huating, Garzon, Ramiro, Sun, Hao, Ladner, Katherine J., Singh, Ravi, Dahlman, Jason, Cheng, Alfred, Hall, Brett M., Qualman, Stephen J., Chandler, Dawn S., Croce, Carlo M., Guttridge, Denis C.
Julkaistu 2008

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

Tekijä Voorhees, Peter M., Manges, Robert F., Sonneveld, Pieter, Jagannath, Sundar, Somlo, George, Krishnan, Amrita, Lentzsch, Suzanne, Frank, Richard C., Zweegman, Sonja, Wijermans, Pierre W., Orlowski, Robert Z., Kranenburg, Britte, Hall, Brett, Casneuf, Tineke, Qin, Xiang, van de Velde, Helgi, Xie, Hong, Thomas, Sheeba K.
Julkaisussa Br J Haematol (2013)